3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, B-Cell
2
Colorectal Neoplasms
2
Carcinoma
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Platinum-resistant Ovarian Cancer
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Microsatellite Instability
1
Melanoma
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
34
Doxorubicin
24
fludarabine phosphate
20
Vinblastine
20
Nivolumab
20
Dacarbazine
20
Brentuximab Vedotin
20
pembrolizumab
19
fludarabine
18
Mycophenolic Acid
17
Whole-Body Irradiation
15
Etoposide
14
Filgrastim
13
Melphalan
12
Granulocyte Colony-Stimulating Factor
10
Gemcitabine
10
Bleomycin
10
Tacrolimus
9
Radiotherapy
9
Prednisone
9
Peripheral Blood Stem Cell Transplantation
9
Busulfan
9
Specimen Handling
8
Vincristine
7
Sirolimus
7
Magnetic Resonance Spectroscopy
7
Cyclosporine
7
pegfilgrastim
6
Stem Cell Transplantation
6
Bendamustine Hydrochloride
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
ALT-803
×
1 year
×
Clear all
No trials found.